Modeling miRNA regulation in cancer signaling systems: miR-34a regulation of the p53/Sirt1 signaling module
- PMID: 23361983
- DOI: 10.1007/978-1-61779-833-7_6
Modeling miRNA regulation in cancer signaling systems: miR-34a regulation of the p53/Sirt1 signaling module
Abstract
MicroRNAs (miRNAs) are a family of small regulatory RNAs whose function is to regulate the activity and stability of specific messenger RNA _targets through posttranscriptional regulatory mechanisms. Most of the times signaling systems involving miRNA modulation are not linear pathways in which a certain transcription factor activate the expression of miRNAs that posttranscriptionally represses _targeting proteins, but complex regulatory structures involving a variety of feedback-loop architectures.In this book chapter, we define, discuss, and apply a Systems Biology approach to investigate dynamical features of miRNA regulation, based on the integration of experimental evidences, hypotheses, and quantitative data through mathematical modeling. We further illustrate the approach using as case study the signaling module composed by the proteins p53, Sirt1, and the regulatory miRNA miR-34a. The model was used not only to investigate different possible designs of the silencing mechanism exerted by miR-34a on Sirt1 but also to simulate the dynamics of the system under conditions of (pathological) deregulation of its compounds.
Similar articles
-
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.J Hepatol. 2013 Jan;58(1):119-25. doi: 10.1016/j.jhep.2012.08.008. Epub 2012 Aug 15. J Hepatol. 2013. PMID: 22902550
-
SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.Toxicol Appl Pharmacol. 2014 Jun 15;277(3):288-97. doi: 10.1016/j.taap.2014.04.001. Epub 2014 Apr 12. Toxicol Appl Pharmacol. 2014. PMID: 24726431
-
MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007. Arch Med Res. 2010. PMID: 20470934
-
MicroRNA-181a - a tale of discrepancies.Expert Rev Mol Med. 2012 Feb 21;14:e5. doi: 10.1017/S1462399411002122. Expert Rev Mol Med. 2012. PMID: 22348355 Review.
-
Potential microRNA therapies _targeting Ras, NFkappaB and p53 signaling.Curr Opin Mol Ther. 2010 Apr;12(2):147-57. Curr Opin Mol Ther. 2010. PMID: 20373258 Review.
Cited by
-
Understanding microRNA-mediated gene regulatory networks through mathematical modelling.Nucleic Acids Res. 2016 Jul 27;44(13):6019-35. doi: 10.1093/nar/gkw550. Epub 2016 Jun 17. Nucleic Acids Res. 2016. PMID: 27317695 Free PMC article.
-
MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance.Theranostics. 2018 Jan 1;8(4):1106-1120. doi: 10.7150/thno.19904. eCollection 2018. Theranostics. 2018. PMID: 29464002 Free PMC article.
-
Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.Cancer Med. 2023 Dec;12(24):22130-22155. doi: 10.1002/cam4.6719. Epub 2023 Nov 21. Cancer Med. 2023. PMID: 37987212 Free PMC article. Review.
-
Senescence-Associated MicroRNAs.Int Rev Cell Mol Biol. 2017;334:177-205. doi: 10.1016/bs.ircmb.2017.03.008. Epub 2017 Apr 28. Int Rev Cell Mol Biol. 2017. PMID: 28838538 Free PMC article. Review.
-
miR-574-3p acts as a tumor promoter in osteosarcoma by _targeting SMAD4 signaling pathway.Oncol Lett. 2016 Dec;12(6):5247-5253. doi: 10.3892/ol.2016.5355. Epub 2016 Nov 7. Oncol Lett. 2016. PMID: 28105233 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
